These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36284469)

  • 1. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms.
    Hecht ES; Mehta S; Wecksler AT; Aguilar B; Swanson N; Phung W; Dubey Kelsoe A; Benner WH; Tesar D; Kelley RF; Sandoval W; Sreedhara A
    MAbs; 2022; 14(1):2135183. PubMed ID: 36284469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.
    Hall T; Sandefur SL; Frye CC; Tuley TL; Huang L
    J Pharm Sci; 2016 May; 105(5):1633-1642. PubMed ID: 27056628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating interactions between phospholipase B-Like 2 and antibodies during Protein A chromatography.
    Tran B; Grosskopf V; Wang X; Yang J; Walker D; Yu C; McDonald P
    J Chromatogr A; 2016 Mar; 1438():31-8. PubMed ID: 26896920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting product association as a mechanism of host-cell protein persistence in bioprocessing.
    Oh YH; Becker ML; Mendola KM; Choe LH; Min L; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2024 Apr; 121(4):1284-1297. PubMed ID: 38240126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Sensitive LC-MS/MS Method for Targeted Quantitation of Lipase Host Cell Proteins in Biotherapeutics.
    Chen Y; Xu CF; Stanley B; Evangelist G; Brinkmann A; Liu S; McCarthy S; Xiong L; Jones E; Sosic Z; Yeung B
    J Pharm Sci; 2021 Dec; 110(12):3811-3818. PubMed ID: 34461112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
    Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
    MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations.
    Maier M; Weiß L; Zeh N; Schmieder-Todtenhaupt V; Dehghani A; Felix MN; Heinzelmann D; Lindner B; Schmidt M; Studts J; Schulz P; Reisinger B; Otte K; Franzreb M; Lakatos D; Fischer S
    MAbs; 2024; 16(1):2375798. PubMed ID: 38984665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ELISA Antibody-Antigen Interaction using Footprinting-Mass Spectrometry and Negative Staining Transmission Electron Microscopy.
    Lin M; Krawitz D; Callahan MD; Deperalta G; Wecksler AT
    J Am Soc Mass Spectrom; 2018 May; 29(5):961-971. PubMed ID: 29512051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling.
    Li X; Chandra D; Letarte S; Adam GC; Welch J; Yang RS; Rivera S; Bodea S; Dow A; Chi A; Strulson CA; Richardson DD
    Anal Chem; 2021 Jun; 93(23):8161-8169. PubMed ID: 34032423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.
    Chiu J; Valente KN; Levy NE; Min L; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2017 May; 114(5):1006-1015. PubMed ID: 27943242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
    Zhang Z; Yan Y; Wang S; Li N
    MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
    Levy NE; Valente KN; Lee KH; Lenhoff AM
    Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material.
    Fischer SK; Cheu M; Peng K; Lowe J; Araujo J; Murray E; McClintock D; Matthews J; Siguenza P; Song A
    AAPS J; 2017 Jan; 19(1):254-263. PubMed ID: 27739010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.
    E SY; Hu Y; Molden R; Qiu H; Li N
    J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing.
    Oh YH; Mendola KM; Choe LH; Min L; Lavoie AR; Sripada SA; Williams TI; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2024 Jan; 121(1):291-305. PubMed ID: 37877536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic polymer precipitation for enhanced impurity removal in downstream processing.
    Li Z; Chen J; Martinez-Fonts K; Rauscher M; Rivera S; Welsh J; Kandula S
    Biotechnol Bioeng; 2023 Jul; 120(7):1902-1913. PubMed ID: 37148495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More similar than different: Host cell protein production using three null CHO cell lines.
    Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
    Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation.
    Graf T; Tomlinson A; Yuk IH; Kufer R; Spensberger B; Falkenstein R; Shen A; Li H; Duan D; Liu W; Wohlrab S; Edelmann F; Leiss M
    J Pharm Sci; 2021 Nov; 110(11):3558-3567. PubMed ID: 34224732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
    Zhang S; Xiao H; Goren M; Burakov D; Chen G; Li N; Tustian A; Adams B; Mattila J; Bak H
    J Pharm Sci; 2020 Sep; 109(9):2710-2718. PubMed ID: 32534029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.